Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Conte

Showing results (211-220 of 368) with videos related to

Pageof 37
Sort By:
Hormone Research|March 17, 2001
Evaluation of cutaneous modifications in seventy-seven growth hormone-deficient childrenF Conte, S Diridollou, B Jouret, et al.
Anticancer Research|February 24, 2001
p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimenA Gadducci, C Cianci, S Cosio, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaksM Andreuccetti, G Allegrini, A Antonuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 10, 2013
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patientsV Guarneri, M V Dieci, E Barbieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patientsA Falcone, R Danesi, F Dargenio, et al.
European Journal of Clinical Pharmacology|February 27, 2003
Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case reportG Bocci, R Danesi, G Allegrini, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|April 14, 2012
Classification of the geographical origin of Italian donkey's milk based on differences in inorganic anionsG Di Bella, V Lo Turco, A G Potortì, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Tumour kinetics, response to chemotherapy and survival in primary ovarian cancerA Alama, S Chiara, F Merlo, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1985
High dose cisplatin after failure of polychemotherapy containing cisplatin in ovarian cancer. Preliminary resultsM Bruzzone, P F Conte, S Chiara, et al.
American Journal of Clinical Oncology|August 24, 2000
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumorsS Ricci, A Antonuzzo, L Galli, et al.
Pageof 37

Showing results (211-220 of 368) with videos related to

Sort By:
Pageof 37
Hormone Research|March 17, 2001
Evaluation of cutaneous modifications in seventy-seven growth hormone-deficient childrenF Conte, S Diridollou, B Jouret, et al.
Anticancer Research|February 24, 2001
p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimenA Gadducci, C Cianci, S Cosio, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaksM Andreuccetti, G Allegrini, A Antonuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 10, 2013
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patientsV Guarneri, M V Dieci, E Barbieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patientsA Falcone, R Danesi, F Dargenio, et al.
European Journal of Clinical Pharmacology|February 27, 2003
Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case reportG Bocci, R Danesi, G Allegrini, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|April 14, 2012
Classification of the geographical origin of Italian donkey's milk based on differences in inorganic anionsG Di Bella, V Lo Turco, A G Potortì, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Tumour kinetics, response to chemotherapy and survival in primary ovarian cancerA Alama, S Chiara, F Merlo, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1985
High dose cisplatin after failure of polychemotherapy containing cisplatin in ovarian cancer. Preliminary resultsM Bruzzone, P F Conte, S Chiara, et al.
American Journal of Clinical Oncology|August 24, 2000
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumorsS Ricci, A Antonuzzo, L Galli, et al.
Pageof 37